Algernon Pharmaceuticals Financials
| AGNPF Stock | USD 0.06 0.01 17.00% |
With this module, you can analyze Algernon financials for your investing period. You should be able to track the changes in Algernon Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Algernon |
Understanding current and past Algernon Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Algernon Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Algernon Pharmaceuticals' assets may result in an increase in income on the income statement.
The data published in Algernon Pharmaceuticals' official financial statements typically reflect Algernon Pharmaceuticals' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Algernon Pharmaceuticals' quantitative information. For example, before you start analyzing numbers published by Algernon accountants, it's essential to understand Algernon Pharmaceuticals' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Algernon Pharmaceuticals Stock Summary
Algernon Pharmaceuticals competes with Cellectis, Covalon Technologies, Ascletis Pharma, GH Research, and Mosaic Immunoengineerin. Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. Algernon Pharmaceuticals is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 700 West Pender |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | algernonpharmaceuticals.com |
| Phone | 604 398 4175 |
| Currency | USD - US Dollar |
Algernon Pharmaceuticals Key Financial Ratios
There are many critical financial ratios that Algernon Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Algernon Pharmaceuticals reports annually and quarterly.| Return On Equity | -1.09 | |||
| Return On Asset | -0.53 | |||
| Beta | 0.32 |
Algernon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Algernon Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Algernon Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Algernon Pharmaceuticals competition to find correlations between indicators driving Algernon Pharmaceuticals's intrinsic value. More Info.Algernon Pharmaceuticals is rated fourth in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Algernon Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Algernon Pharmaceuticals Systematic Risk
Algernon Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Algernon Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Algernon Pharmaceuticals correlated with the market. If Beta is less than 0 Algernon Pharmaceuticals generally moves in the opposite direction as compared to the market. If Algernon Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Algernon Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Algernon Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Algernon Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Algernon Pharmaceuticals February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Algernon Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Algernon Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Algernon Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Algernon OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Algernon Pharmaceuticals's daily price indicators and compare them against related drivers.
| Downside Deviation | 9.23 | |||
| Information Ratio | 0.0594 | |||
| Maximum Drawdown | 34.73 | |||
| Value At Risk | (11.54) | |||
| Potential Upside | 12.55 |
Complementary Tools for Algernon OTC Stock analysis
When running Algernon Pharmaceuticals' price analysis, check to measure Algernon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Algernon Pharmaceuticals is operating at the current time. Most of Algernon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Algernon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Algernon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Algernon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |